All In MedTech

Device Trial Radar · NCT00559013

Peri-Strips Dry (PSD) Veritas Collagen Matrix Staple Line Reinforcement for Colorectal Surgery

Peri-Strips Dry With Veritas Collagen Matrix Staple Line Reinforcement for Colorectal Surgery

Last checked: Nov 20, 2026Latest source record: May 10, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

38

Actual

Start

Mar 2007

Primary completion

Dec 2008

Study completion Dec 2008

Sponsor

Lead sponsor
Baxter Healthcare CorporationPublic (BAX)
Sponsor type
Industry
Collaborators
Synovis Surgical Innovations
First posted
Nov 16, 2007

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Prevention
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Purpose of the study is to assess the utility of PSD Veritas as a staple line reinforcement to minimize the risk of leakage during or after colo-rectal surgery.

Conditions

  • Colorectal Cancer

Interventions

  • Staple line reinforcementDevice

    Placement of reinforcement material on circular anastomotic staple line for prevention of leak during and post surgery.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Major Colorectal Related Adverse Events: Leak, Stricture and Hemorrhage.Time frame: Discharge and 1 Month post surgery

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Lahey Clinic

    Burlington, Massachusetts

  • Colon & Rectal Surgery Associates

    Saint Paul, Minnesota

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.